VEGFA and age-related macular degeneration: With regards to secondary prevention, more attention should be paid to the health care costs of late AMD, especially for nvAMD for which progression to the loss of sight could be slowed by photodynamic therapy (PDT) or intravitreal (IVT) anti-VEGF.